SAN FRANCISCO, March 29, 2017 /PRNewswire/ -- Constance Finley, Founder and CEO of Constance Therapeutics, has been newly appointed to the Scientific Advisory Board of CannaTech. The appointment stems from her recent speaking engagement at CannaTech, the world's leading cannabis industry conference at whose recent Tel Aviv event Finley was a featured presenter.
Finley's speech at CannaTech, "Taking Cannabis Seriously: Farm to Tablet Stories from the California Experiment," detailed the history of Constance Therapeutics (the first company in California to professionalize and standardize cannabis formulations for medicinal use) and recounted her personal journey (from gravely ill patient to the discovery of cannabis treatments to her current place as the global pioneer in whole-flower extraction). She also spoke on the "Exploring the Holy Trinity of Botanical, Biosynthesis & Synthetics" panel, which focused on global healthcare systems' failure to use cannabis medicinally and how that paradigm might be changed in future.
As part of her new role at CannaTech, Finley will be appearing at both of the 2017 CannaTech Global conferences, to be held in London and Sydney. As a member of the scientific advisory board, Finley will advise CannaTech on next generation medical and scientific advancements, as well as assist in the planning of CannaTech's medical agenda.
"CannaTech Israel's conference in Tel Aviv potentiated the best of what's happening currently in medicinal cannabis globally: serious, cutting-edge science and business alliances of the highest order. I was anxious to attend but now am looking forward even more to continued participation. CannaTech 2017 Israel is the best run conference I've attended in any industry." – Constance Finley, Founder and CEO of Constance Therapeutics.
Finley was recognized at CannaTech for her industry leadership, her company's work to increase public knowledge about the medicinal benefits of cannabis and reduce the stigma around medicinal cannabis, its innovative whole-flower (CBD/THC) extracts to treat athletes and other patients with serious medical conditions, and its groundbreaking patient care system. In addition to CannaTech, Finley has been a featured presenter at SXSW, The California Academy of Sciences, the Cure Cancer Now Summit, the ICRS, CWCBExpo, and the Cannabis Quality Strategies and Solutions Summit.
"Constance is a visionary and cannabis industry leader. We were honored to include her in CannaTech Tel Aviv and we look forward to her continued contribution as scientific adviser and presenter to CannaTech Global in London and Sydney." – Saul Kaye, CEO of iCAN: Israel Cannabis, parent organization of CannaTech.
About Constance Therapeutics
Constance Therapeutics is a vertically integrated medicinal cannabis company producing standardized and science-based whole-plant cannabis extracts. The company has created a new category of whole-plant cannabis extracts that fills the gap between traditional pharmaceuticals and commonplace cannabis products, providing much needed additional treatment options to physicians and their patients. Constance Therapeutics' extracts are derived from fully trimmed, female unfertilized cannabis sativa flowers of plants with known genetics using certified-organic, pharmaceutical-grade ethanol via a highly controlled, quantitatively-defined and patented process that is based on solid scientific and engineering principles. Extracts are systematically third-party tested and routinely cross-tested in the industry's most respected laboratories. Since 2008, the company has employed stringent, science-based processes and standards to ensure the highest quality and consistency. Headquartered in San Francisco, California, Constance Therapeutics' cannabis extracts are available exclusively for therapeutic use and can only be purchased by registered California patients, in keeping with Proposition 215, and California Senate Bill 420. For further information, visit: www.constancetherapeutics.com.
About CannaTech
CannaTech, powered by iCAN: Israel-Cannabis, is a high-level, three day event series featuring the biggest thought leaders and market disruptors in medical cannabis across the globe. CannaTech showcases the full spectrum of global industry leaders, spanning the fields of science, research, finance, medicine, government policy, tech innovation, agriculture & entrepreneurship, at one outstanding event with a singular focus on cannabis and all the opportunity that surrounds it. For details, visit: www.canna-tech.co.
SOURCE Constance Therapeutics